Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1997 Mar;105(Suppl 2):417–436. doi: 10.1289/ehp.97105s2417

Profile of patients with chemical injury and sensitivity.

G Ziem 1, J McTamney 1
PMCID: PMC1469804  PMID: 9167975

Abstract

Patients reporting sensitivity to multiple chemicals at levels usually tolerated by the healthy population were administered standardized questionnaires to evaluate their symptoms and the exposures that aggravated these symptoms. Many patients were referred for medical tests. It is thought that patients with chemical sensitivity have organ abnormalities involving the liver, nervous system (brain, including limbic, peripheral, autonomic), immune system, and porphyrin metabolism, probably reflecting chemical injury to these systems. Laboratory results are not consistent with a psychologic origin of chemical sensitivity. Substantial overlap between chemical sensitivity, fibromyalgia, and chronic fatigue syndrome exists: the latter two conditions often involve chemical sensitivity and may even be the same disorder. Other disorders commonly seen in chemical sensitivity patients include headache (often migraine), chronic fatigue, musculoskeletal aching, chronic respiratory inflammation (rhinitis, sinusitis, laryngitis, asthma), attention deficit, and hyperactivity (affected younger children). Less common disorders include tremor, seizures, and mitral valve prolapse. Patients with these overlapping disorders should be evaluated for chemical sensitivity and excluded from control groups in future research. Agents whose exposures are associated with symptoms and suspected of causing onset of chemical sensitivity with chronic illness include gasoline, kerosene, natural gas, pesticides (especially chlordane and chlorpyrifos), solvents, new carpet and other renovation materials, adhesives/glues, fiberglass, carbonless copy paper, fabric softener, formaldehyde and glutaraldehyde, carpet shampoos (lauryl sulfate) and other cleaning agents, isocyanates, combustion products (poorly vented gas heaters, overheated batteries), and medications (dinitrochlorobenzene for warts, intranasally packed neosynephrine, prolonged antibiotics, and general anesthesia with petrochemicals). Multiple mechanisms of chemical injury that magnify response to exposures in chemically sensitive patients can include neurogenic inflammation (respiratory, gastrointestinal, genitourinary), kindling and time-dependent sensitization (neurologic), impaired porphyrin metabolism (multiple organs), and immune activation.

Full text

PDF
417

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aggazzotti G., Fantuzzi G., Tartoni P. L., Predieri G. Plasma chloroform concentrations in swimmers using indoor swimming pools. Arch Environ Health. 1990 May-Jun;45(3):175–179. doi: 10.1080/00039896.1990.9936712. [DOI] [PubMed] [Google Scholar]
  2. Bell I. R., Miller C. S., Schwartz G. E. An olfactory-limbic model of multiple chemical sensitivity syndrome: possible relationships to kindling and affective spectrum disorders. Biol Psychiatry. 1992 Aug 1;32(3):218–242. doi: 10.1016/0006-3223(92)90105-9. [DOI] [PubMed] [Google Scholar]
  3. Bell I. R. White paper: Neuropsychiatric aspects of sensitivity to low-level chemicals: a neural sensitization model. Toxicol Ind Health. 1994 Jul-Oct;10(4-5):277–312. [PubMed] [Google Scholar]
  4. Bickers D. R., Miller L., Kappas A. Exacerbation of hereditary hepatic porphyria by surreptitious ingestion of an unusual provacative agent--a mouthwash preparation. N Engl J Med. 1975 May 22;292(21):1115–1116. doi: 10.1056/NEJM197505222922109. [DOI] [PubMed] [Google Scholar]
  5. Bocchetta A., Corsini G. U. Parkinson's disease and pesticides. Lancet. 1986 Nov 15;2(8516):1163–1163. doi: 10.1016/s0140-6736(86)90576-3. [DOI] [PubMed] [Google Scholar]
  6. Bombassei G. J., Kaplan A. A. The association between hydrocarbon exposure and anti-glomerular basement membrane antibody-mediated disease (Goodpasture's syndrome). Am J Ind Med. 1992;21(2):141–153. doi: 10.1002/ajim.4700210204. [DOI] [PubMed] [Google Scholar]
  7. Broughton A., Thrasher J. D., Gard Z. Immunological evaluation of four arc welders exposed to fumes from ignited polyurethane (isocyanate) foam: antibodies and immune profiles. Am J Ind Med. 1988;13(4):463–472. doi: 10.1002/ajim.4700130406. [DOI] [PubMed] [Google Scholar]
  8. Buchwald D., Garrity D. Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities. Arch Intern Med. 1994 Sep 26;154(18):2049–2053. [PubMed] [Google Scholar]
  9. Byers V. S., Levin A. S., Ozonoff D. M., Baldwin R. W. Association between clinical symptoms and lymphocyte abnormalities in a population with chronic domestic exposure to industrial solvent-contaminated domestic water supply and a high incidence of leukaemia. Cancer Immunol Immunother. 1988;27(1):77–81. doi: 10.1007/BF00205762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Callender T. J., Morrow L., Subramanian K., Duhon D., Ristovv M. Three-dimensional brain metabolic imaging in patients with toxic encephalopathy. Environ Res. 1993 Feb;60(2):295–319. doi: 10.1006/enrs.1993.1039. [DOI] [PubMed] [Google Scholar]
  11. Callender T. J., Morrow L., Subramanian K., Duhon D., Ristovv M. Three-dimensional brain metabolic imaging in patients with toxic encephalopathy. Environ Res. 1993 Feb;60(2):295–319. doi: 10.1006/enrs.1993.1039. [DOI] [PubMed] [Google Scholar]
  12. Callender T. J., Morrow L., Subramanian K. Evaluation of chronic neurological sequelae after acute pesticide exposure using SPECT brain scans. J Toxicol Environ Health. 1994 Mar;41(3):275–284. doi: 10.1080/15287399409531843. [DOI] [PubMed] [Google Scholar]
  13. Castleman B. I., Ziem G. E. American Conference of Governmental Industrial Hygienists: low threshold of credibility. Am J Ind Med. 1994 Jul;26(1):133–143. doi: 10.1002/ajim.4700260112. [DOI] [PubMed] [Google Scholar]
  14. Castleman B. I., Ziem G. E. Corporate influence on threshold limit values. Am J Ind Med. 1988;13(5):531–559. doi: 10.1002/ajim.4700130503. [DOI] [PubMed] [Google Scholar]
  15. Castleman B. I., Ziem G. E. Toxic pollutants, science, and corporate influence. Arch Environ Health. 1989 Mar-Apr;44(2):68–127. doi: 10.1080/00039896.1989.9934377. [DOI] [PubMed] [Google Scholar]
  16. Cone J. E., Sult T. A. Acquired intolerance to solvents following pesticide/solvent exposure in a building: a new group of workers at risk for multiple chemical sensitivities? Toxicol Ind Health. 1992 Jul-Aug;8(4):29–39. [PubMed] [Google Scholar]
  17. Cotton P. Treatment proposed for chronic fatigue syndrome; research continues to compile data on disorder. JAMA. 1991 Nov 20;266(19):2667–2668. [PubMed] [Google Scholar]
  18. Daniell W. E., Couser W. G., Rosenstock L. Occupational solvent exposure and glomerulonephritis. A case report and review of the literature. JAMA. 1988 Apr 15;259(15):2280–2283. [PubMed] [Google Scholar]
  19. Davidoff A. L., Fogarty L. Psychogenic origins of multiple chemical sensitivities syndrome: a critical review of the research literature. Arch Environ Health. 1994 Sep-Oct;49(5):316–325. doi: 10.1080/00039896.1994.9954981. [DOI] [PubMed] [Google Scholar]
  20. Davidoff A. L., Keyl P. M. Symptoms and health status in individuals with multiple chemical sensitivities syndrome from four reported sensitizing exposures and a general population comparison group. Arch Environ Health. 1996 May-Jun;51(3):201–213. doi: 10.1080/00039896.1996.9936017. [DOI] [PubMed] [Google Scholar]
  21. Denkhaus W., von Steldern D., Botzenhardt U., Konietzko H. Lymphocyte subpopulations in solvent-exposed workers. Int Arch Occup Environ Health. 1986;57(2):109–115. doi: 10.1007/BF00381378. [DOI] [PubMed] [Google Scholar]
  22. Doty R. L., Deems D. A., Frye R. E., Pelberg R., Shapiro A. Olfactory sensitivity, nasal resistance, and autonomic function in patients with multiple chemical sensitivities. Arch Otolaryngol Head Neck Surg. 1988 Dec;114(12):1422–1427. doi: 10.1001/archotol.1988.01860240072027. [DOI] [PubMed] [Google Scholar]
  23. Fiedler N., Maccia C., Kipen H. Evaluation of chemically sensitive patients. J Occup Med. 1992 May;34(5):529–538. [PubMed] [Google Scholar]
  24. Fowler B. A., Oskarsson A., Woods J. S. Metal- and metalloid-induced porphyrinurias. Relationships to cell injury. Ann N Y Acad Sci. 1987;514:172–182. doi: 10.1111/j.1749-6632.1987.tb48772.x. [DOI] [PubMed] [Google Scholar]
  25. Goldenberg D. L., Simms R. W., Geiger A., Komaroff A. L. High frequency of fibromyalgia in patients with chronic fatigue seen in a primary care practice. Arthritis Rheum. 1990 Mar;33(3):381–387. doi: 10.1002/art.1780330311. [DOI] [PubMed] [Google Scholar]
  26. Gyntelberg F., Vesterhauge S., Fog P., Isager H., Zillstorff K. Acquired intolerance to organic solvents and results of vestibular testing. Am J Ind Med. 1986;9(4):363–370. doi: 10.1002/ajim.4700090408. [DOI] [PubMed] [Google Scholar]
  27. Hafler D. A., Fox D. A., Benjamin D., Weiner H. L. Antigen reactive memory T cells are defined by Ta1. J Immunol. 1986 Jul 15;137(2):414–418. [PubMed] [Google Scholar]
  28. Hagstadius S., Orbaek P., Risberg J., Lindgren M. Regional cerebral blood flow at the time of diagnosis of chronic toxic encephalopathy induced by organic-solvent exposure and after the cessation of exposure. Scand J Work Environ Health. 1989 Apr;15(2):130–135. doi: 10.5271/sjweh.1872. [DOI] [PubMed] [Google Scholar]
  29. Haustein U. F., Ziegler V. Environmentally induced systemic sclerosis-like disorders. Int J Dermatol. 1985 Apr;24(3):147–151. doi: 10.1111/j.1365-4362.1985.tb05745.x. [DOI] [PubMed] [Google Scholar]
  30. Kipen H. M., Hallman W., Kelly-McNeil K., Fiedler N. Measuring chemical sensitivity prevalence: a questionnaire for population studies. Am J Public Health. 1995 Apr;85(4):574–577. doi: 10.2105/ajph.85.4.574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Klimas N. G., Salvato F. R., Morgan R., Fletcher M. A. Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol. 1990 Jun;28(6):1403–1410. doi: 10.1128/jcm.28.6.1403-1410.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Linz D. H., de Garmo P. L., Morton W. E., Wiens A. N., Coull B. M., Maricle R. A. Organic solvent-induced encephalopathy in industrial painters. J Occup Med. 1986 Feb;28(2):119–125. [PubMed] [Google Scholar]
  33. Madison R. E., Broughton A., Thrasher J. D. Immunologic biomarkers associated with an acute exposure to exothermic byproducts of a ureaformaldehyde spill. Environ Health Perspect. 1991 Aug;94:219–223. doi: 10.1289/ehp.94-1567939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Matikainen E., Juntunen J. Autonomic nervous system dysfunction in workers exposed to organic solvents. J Neurol Neurosurg Psychiatry. 1985 Oct;48(10):1021–1024. doi: 10.1136/jnnp.48.10.1021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. McConnachie P. R., Zahalsky A. C. Immune alterations in humans exposed to the termiticide technical chlordane. Arch Environ Health. 1992 Jul-Aug;47(4):295–301. doi: 10.1080/00039896.1992.9938365. [DOI] [PubMed] [Google Scholar]
  36. Meggs W. J., Cleveland C. H., Jr Rhinolaryngoscopic examination of patients with the multiple chemical sensitivity syndrome. Arch Environ Health. 1993 Jan-Feb;48(1):14–18. doi: 10.1080/00039896.1993.9938388. [DOI] [PubMed] [Google Scholar]
  37. Meggs W. J. Neurogenic inflammation and sensitivity to environmental chemicals. Environ Health Perspect. 1993 Aug;101(3):234–238. doi: 10.1289/ehp.93101234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Middaugh D. A., Pinney S. M., Linz D. H. Sick building syndrome. Medical evaluation of two work forces. J Occup Med. 1992 Dec;34(12):1197–1203. [PubMed] [Google Scholar]
  39. Morata T. C., Dunn D. E., Kretschmer L. W., Lemasters G. K., Keith R. W. Effects of occupational exposure to organic solvents and noise on hearing. Scand J Work Environ Health. 1993 Aug;19(4):245–254. doi: 10.5271/sjweh.1477. [DOI] [PubMed] [Google Scholar]
  40. Morrow L. A., Ryan C. M., Hodgson M. J., Robin N. Alterations in cognitive and psychological functioning after organic solvent exposure. J Occup Med. 1990 May;32(5):444–450. doi: 10.1097/00043764-199005000-00010. [DOI] [PubMed] [Google Scholar]
  41. Morrow L. A., Ryan C. M., Hodgson M. J., Robin N. Risk factors associated with persistence of neuropsychological deficits in persons with organic solvent exposure. J Nerv Ment Dis. 1991 Sep;179(9):540–545. doi: 10.1097/00005053-199109000-00004. [DOI] [PubMed] [Google Scholar]
  42. Norbäck D., Björnsson E., Janson C., Widström J., Boman G. Asthmatic symptoms and volatile organic compounds, formaldehyde, and carbon dioxide in dwellings. Occup Environ Med. 1995 Jun;52(6):388–395. doi: 10.1136/oem.52.6.388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Press R. I., Peebles C. L., Kumagai Y., Ochs R. L., Tan E. M. Antinuclear autoantibodies in women with silicone breast implants. Lancet. 1992 Nov 28;340(8831):1304–1307. doi: 10.1016/0140-6736(92)92491-w. [DOI] [PubMed] [Google Scholar]
  44. RIMINGTON C., ZIEGLER G. EXPERIMENTAL PORPHYRIA IN RATS INDUCED BY CHLORINATED BENZENES. Biochem Pharmacol. 1963 Dec;12:1387–1397. doi: 10.1016/0006-2952(63)90208-9. [DOI] [PubMed] [Google Scholar]
  45. Roach S. A., Rappaport S. M. But they are not thresholds: a critical analysis of the documentation of Threshold Limit Values. Am J Ind Med. 1990;17(6):727–753. doi: 10.1002/ajim.4700170607. [DOI] [PubMed] [Google Scholar]
  46. Ryan C. M., Morrow L. A., Hodgson M. Cacosmia and neurobehavioral dysfunction associated with occupational exposure to mixtures of organic solvents. Am J Psychiatry. 1988 Nov;145(11):1442–1445. doi: 10.1176/ajp.145.11.1442. [DOI] [PubMed] [Google Scholar]
  47. Safran M., Paul T. L., Roti E., Braverman L. E. Environmental factors affecting autoimmune thyroid disease. Endocrinol Metab Clin North Am. 1987 Jun;16(2):327–342. [PubMed] [Google Scholar]
  48. Savage E. P., Keefe T. J., Mounce L. M., Heaton R. K., Lewis J. A., Burcar P. J. Chronic neurological sequelae of acute organophosphate pesticide poisoning. Arch Environ Health. 1988 Jan-Feb;43(1):38–45. doi: 10.1080/00039896.1988.9934372. [DOI] [PubMed] [Google Scholar]
  49. Simon G. E., Daniell W., Stockbridge H., Claypoole K., Rosenstock L. Immunologic, psychological, and neuropsychological factors in multiple chemical sensitivity. A controlled study. Ann Intern Med. 1993 Jul 15;119(2):97–103. doi: 10.7326/0003-4819-119-2-199307150-00001. [DOI] [PubMed] [Google Scholar]
  50. Slade M. S., Simmons R. L., Yunis E., Greenberg L. J. Immunodepression after major surgery in normal patients. Surgery. 1975 Sep;78(3):363–372. [PubMed] [Google Scholar]
  51. Sorg B. A., Hooks M. S., Kalivas P. W. Neuroanatomy and neurochemical mechanisms of time-dependent sensitization. Toxicol Ind Health. 1994 Jul-Oct;10(4-5):369–386. [PubMed] [Google Scholar]
  52. Thrasher J. D., Broughton A., Madison R. Immune activation and autoantibodies in humans with long-term inhalation exposure to formaldehyde. Arch Environ Health. 1990 Jul-Aug;45(4):217–223. doi: 10.1080/00039896.1990.9940805. [DOI] [PubMed] [Google Scholar]
  53. Thrasher J. D., Madison R., Broughton A., Gard Z. Building-related illness and antibodies to albumin conjugates of formaldehyde, toluene diisocyanate, and trimellitic anhydride. Am J Ind Med. 1989;15(2):187–195. doi: 10.1002/ajim.4700150207. [DOI] [PubMed] [Google Scholar]
  54. Tröster A. I., Ruff R. M. Neuropsychological sequelae of exposure to the chlorinated hydrocarbon solvents trichloroethylene and trichloroethane. Arch Clin Neuropsychol. 1990;5(1):31–47. [PubMed] [Google Scholar]
  55. Tønnesen E., Hüttel M. S., Christensen N. J., Schmitz O. Natural killer cell activity in patients undergoing upper abdominal surgery: relationship to the endocrine stress response. Acta Anaesthesiol Scand. 1984 Dec;28(6):654–660. doi: 10.1111/j.1399-6576.1984.tb02140.x. [DOI] [PubMed] [Google Scholar]
  56. Ziem G. E., Castleman B. I. Threshold limit values: historical perspectives and current practice. J Occup Med. 1989 Nov;31(11):910–918. doi: 10.1097/00043764-198911000-00014. [DOI] [PubMed] [Google Scholar]
  57. Ziem G., Donnay A. Chronic fatigue, fibromyalgia, and chemical sensitivity: overlapping disorders. Arch Intern Med. 1995 Sep 25;155(17):1913–1913. [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES